Alcyone’s ThecaFlex DRx™ System is an implantable medical device in development for intrathecal drug delivery CAMBRIDGE, Mass. and LOWELL, Mass., Jan. 04, 2023 Biogen Inc. and. | January 4, 2023
Headquartered in Bar Harbor, the biomedical research institute achieved its second-highest grant funding year in 2022; grants related to Alzheimer's and neurodegenerative disease were among the mix.
Biotech start-up Samsara Therapeutics, an early-stage drug discovery company, has expanded into a further 1,000 ft2 of R&D lab space at The Oxford Trust’s Wood Centre for Innovation in Headington, Oxford’s Health and Life Sciences District to accommodate company growth. Click to read more.